|
1
|
Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGF.
|
Blood
|
2005
|
1.17
|
|
2
|
Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer.
|
Clin Cancer Res
|
2004
|
1.01
|
|
3
|
Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.
|
Angiogenesis
|
2007
|
0.89
|
|
4
|
Recombinant anti-EGFR immunotoxin 425(scFv)-ETA' demonstrates anti-tumor activity against disseminated human pancreatic cancer in nude mice.
|
Int J Mol Med
|
2005
|
0.86
|
|
5
|
Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor model.
|
Anticancer Drugs
|
2007
|
0.86
|